8
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Uptake of synthetic naked RNA by skin-resident dendritic cells via macropinocytosis allows antigen expression and induction of T-cell responses in mice.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Intradermal administration of antigen-encoding RNA has entered clinical testing for cancer vaccination. However, insight into the underlying mechanism of RNA uptake, translation and antigen presentation is still limited. Utilizing pharmacologically optimized naked RNA, the dose-response kinetics revealed a rise in reporter signal with increasing RNA amounts and a prolonged RNA translation of reporter protein up to 30 days after intradermal injection. Dendritic cells (DCs) in the dermis were shown to engulf RNA, and the signal arising from the reporter RNA was significantly diminished after DC depletion. Macropinocytosis was relevant for intradermal RNA uptake and translation in vitro and in vivo. By combining intradermal RNA vaccination and inhibition of macropinocytosis, we show that effective priming of antigen-specific CD8(+) T-cells also relies on this uptake mechanism. This report demonstrates that direct antigen translation by dermal DCs after intradermal naked RNA vaccination is relevant for efficient priming of antigen-specific T-cells.

          Related collections

          Author and article information

          Journal
          Cancer Immunol. Immunother.
          Cancer immunology, immunotherapy : CII
          Springer Nature
          1432-0851
          0340-7004
          Sep 2016
          : 65
          : 9
          Affiliations
          [1 ] TRON-Translational Oncology at the University Medical Center of Johannes Gutenberg University gGmbH, Freiligrathstraße 12, 55131, Mainz, Germany.
          [2 ] Research Center for Immunotherapy (FZI), University Medical Center of Johannes Gutenberg University, Mainz, Germany.
          [3 ] Department of Dermatology, University Medical Center of Johannes Gutenberg University, Mainz, Germany.
          [4 ] Cluster for Individualized Immune Intervention (CI3), Mainz, Germany.
          [5 ] BioNTech RNA Pharmaceuticals GmbH, Mainz, Germany.
          [6 ] TRON-Translational Oncology at the University Medical Center of Johannes Gutenberg University gGmbH, Freiligrathstraße 12, 55131, Mainz, Germany. Mustafa.Diken@TrOn-Mainz.de.
          [7 ] BioNTech RNA Pharmaceuticals GmbH, Mainz, Germany. Mustafa.Diken@TrOn-Mainz.de.
          [8 ] TRON-Translational Oncology at the University Medical Center of Johannes Gutenberg University gGmbH, Freiligrathstraße 12, 55131, Mainz, Germany. Sebastian.Kreiter@TrOn-Mainz.de.
          [9 ] BioNTech RNA Pharmaceuticals GmbH, Mainz, Germany. Sebastian.Kreiter@TrOn-Mainz.de.
          Article
          10.1007/s00262-016-1869-7
          10.1007/s00262-016-1869-7
          27422115
          f520a8a1-33cb-477d-9dc6-1fe320f4ac80
          History

          RNA vaccine,Naked RNA,Macropinocytosis,Intradermal vaccination,Dermal dendritic cell,Cancer immunotherapy

          Comments

          Comment on this article